MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
about
microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and ChallengesMicroRNAs: promising new antiangiogenic targets in cancerAngiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart DiseaseExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery diseaseA PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis.MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog.miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression.MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2microRNA alterations in ALDH positive mammary epithelial cells: a crucial contributing factor towards breast cancer risk reduction in case of early pregnancy.MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.miR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing.Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma.MiR-1188 at the imprinted Dlk1-Dio3 domain acts as a tumor suppressor in hepatoma cells.MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1RMolecular Basis of Gene-Gene Interaction: Cyclic Cross-Regulation of Gene Expression and Post-GWAS Gene-Gene Interaction Involved in Atrial Fibrillation.Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer.Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer CellsOverexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2.A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcomaMiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.Post-transcriptional regulation of cardiac sodium channel gene SCN5A expression and function by miR-192-5pCardiac sodium channel regulator MOG1 regulates cardiac morphogenesis and rhythm.miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathwaysUp-regulation of FGFBP1 signaling contributes to miR-146a-induced angiogenesis in human umbilical vein endothelial cells.αB-Crystallin Interacts with Nav1.5 and Regulates Ubiquitination and Internalization of Cell Surface Nav1.5.pol-miR-731, a teleost miRNA upregulated by megalocytivirus, negatively regulates virus-induced type I interferon response, apoptosis, and cell cycle arrest.MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptorCharacterization of FGFR signaling pathway as therapeutic targets for sarcoma patientsIn vivo delivery of miRNAs for cancer therapy: challenges and strategies.SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expressionmiRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancerMicroRNA-503-5p inhibits stretch-induced osteogenic differentiation and bone formation.microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition.MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.
P2860
Q26772746-59F984EE-4448-4372-83E4-557F46F74445Q27027998-17A0AB9F-C46A-4582-A89D-38EB2305C961Q27340828-EFAFAB39-457A-4B29-B6FB-84E046A8E418Q28079163-A5BCB09F-96FB-4162-83EF-36411D6F9235Q28539143-6202BD47-5DD3-421F-A67B-4F136F937AE8Q33746963-33B4F4F2-6021-4A45-9009-14A1CF8101A5Q33843200-C2EB4716-E3D5-4151-8C58-4CE9E8BBD624Q33980238-414A9DF1-3258-42F3-8C9A-58BEDA78AAE8Q34116259-8FDC9C8F-6BFD-4A6E-97B1-C21777BB461AQ34204974-F99A9284-9F22-4913-8E94-FB06961ADD4AQ35032496-F52FDD76-978C-4C91-97F1-F26440A6985FQ35051513-D89C3A9E-91CA-4D64-BA1F-B77EC63F81B8Q35079173-22DED231-07CF-4600-8151-9E525A9207DDQ35229044-91C09022-6B48-4D4A-941A-15E288786659Q35390062-812BE6F1-B8F3-44C2-A454-885E73ECB6D1Q35632595-B768236A-78E0-4B06-BECF-41202A38F286Q35743953-F9A69DA7-6C0A-4CE5-892D-16921B82B362Q35832970-FF1EBDFD-37EA-4F3F-A56C-2B7F08FD76B4Q35854294-F7A33871-5486-4234-8A4F-9E7BCC35BA8DQ35864418-2B6F103D-4508-4402-BEF5-FDBFFB01C131Q36033915-C2E3CCAA-4A2E-4834-985D-C56EC7202D58Q36212307-8B34E054-F959-4526-84E3-234C5A8EBA02Q36262912-4BB2813C-E86C-4C06-A355-4FDBF069289FQ36464350-CCC3A348-57D6-409B-B4D8-2D18CB3E43CAQ36591586-4A9E5A7F-0E40-435C-BBCA-C89B110EA3BAQ36605921-C0D03CEF-DD5F-440B-828D-F765092E42C2Q36772022-E50E61A5-48C9-43A4-B590-B6DCAFA2B918Q36845828-0B64C6BB-7C69-4019-9716-354FF05D9775Q36987607-4823BA86-A184-4AC8-BD4C-C8DE32639D5CQ37014990-70CE3452-E028-450E-998B-7DB08ADDF8FBQ37021246-51C298C8-51E9-4472-A49D-639BDFD4B911Q37094042-C2E8CFBE-0711-4BF9-B58F-793974BBD7DEQ37228217-7BBB1B29-D929-4ECB-8B48-8568EFB55A3DQ37252700-64FF450B-9EEB-4229-83A9-8E47229F15E0Q37307610-D239F769-2A5D-4827-858B-419195C9D8F5Q37412557-2B056352-BF87-45DC-8497-3C639041905FQ37594412-1E5D46C8-B0A5-4856-93A5-251C366CA8AAQ38290132-139B0E8F-DE1D-4F5F-9F05-F0F430AB842AQ38375325-309EE4C7-F2E1-475B-BF21-9C046A8AA7C4Q38663358-C4DC1640-586F-48E9-B79C-37B5CB6A233C
P2860
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
@ast
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
@en
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
@nl
type
label
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
@ast
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
@en
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
@nl
prefLabel
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
@ast
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
@en
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
@nl
P2093
P1433
P1476
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth
@en
P2093
P304
P356
10.1016/J.CANLET.2013.01.028
P407
P50
P577
2013-01-22T00:00:00Z